Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03537248 · ClinicalTrials.gov registry record · NA

A Safety and Effectiveness Study of a New Multi-Purpose Contact Lens Care Solution

A NA study of Contact Lens Wear, sponsored by Asepticys.

Completed
Registry status
NA
Development phase
315
Enrollment target
14
Study locations

NCT03537248 is a NA study of Contact Lens Wear that has completed, run by Asepticys. The registered enrollment target is 315 participants, roughly in line with the 312-participant average among 3 other Contact Lens Wear trials with a reported enrollment target. The trial reports 14 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03537248, a NA study of Contact Lens Wear, has completed, sponsored by Asepticys.

COMPLETED
Registry status
NA
Development phase
315 participants
Enrollment target
14
Study locations

Study Summary

The objective of this study is to evaluate the safety and effectiveness of ASP-57 Multi-Purpose contact lens solution (Test) compared to ReNu® Multiplus Contact Lens Solution (Control) when used by habitual contact lens wearers to bilaterally clean and disinfect their contact lenses for approximately 3 months (12 weeks).

Conditions Studied

Interventions

  • DEVICE ASP-57
  • DEVICE ReNu® Multiplus

Study Locations (14)

Florida

  • Sabal Eye Care - Longwood
  • Maitland Vision Center - Maitland
  • Vision Health Institute - Orlando

California

  • Lakeside Vision Center - Irvine
  • Complete Family Vision Care - San Diego

Kansas

  • Kannarr Eye Care - Pittsburg
  • Heart of America Eye Care - Shawnee Mission

Tennessee

  • Optometry Group - Memphis
  • Optique Eyecare - Nashville

Illinois

  • Eye Care Associates - Bloomington

Maryland

  • Seidenberg Protzko Eye Associates - Havre de Grace

Missouri

  • Insight Eyecare - Warrensburg

Ohio

  • Drs Quinn, Foster & Associates - Athens

Trial Details

FieldValue
Enrollment Target 315 participants
Start Date 2018-04-23
Est. Completion 2018-10-30
Phase NA

Sponsor

Asepticys

1 total trials

What the Registry Record Tells You About NCT03537248

The ClinicalTrials.gov registry entry for NCT03537248 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 312-participant average among 3 other Contact Lens Wear trials with a reported enrollment target. The listed sponsor is Asepticys, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Contact Lens Wear appearing as the primary indexed condition, and to 2 interventions - of which ASP-57 is the first listed.

NCT03537248 reports 14 study locations spanning 9 distinct geographic areas - top geographies include Florida, California, Kansas.

Frequently Asked Questions

What is clinical trial NCT03537248 about?

NCT03537248 is a clinical study titled "A Safety and Effectiveness Study of a New Multi-Purpose Contact Lens Care Solution". The objective of this study is to evaluate the safety and effectiveness of ASP-57 Multi-Purpose contact lens solution (Test) compared to ReNu® Multiplus Contact Lens Solution (Control) when used by habitual contact lens wearers to bilaterally clean and disinfect their contact lenses for approximatel...

What is the current status of trial NCT03537248?

This trial is currently completed. It is a NA study. The enrollment target is 315 participants. The study started on 2018-04-23. Estimated completion is 2018-10-30.

What conditions does trial NCT03537248 study?

This clinical trial studies the following conditions: Contact Lens Wear.

What interventions are being tested in trial NCT03537248?

The interventions under investigation include: ASP-57 (DEVICE), ReNu® Multiplus (DEVICE).

Who is sponsoring clinical trial NCT03537248?

This trial is sponsored by Asepticys, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03537248 being conducted?

This trial has 14 study locations across California, Florida, Illinois, Kansas, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Contact Lens Wear

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.